Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT Admiral drug-coated balloon (DCB) in longer, 150 mm lengths. The new 150 mm-length balloon — available in 4, 5 and 6 mm diameters — will provide greater treatment options for long lesions in patients with peripheral artery disease (PAD).
